Abstract:Genomics and genome screening are proving central to the study of cancer. However, a good appreciation of the protein structures coded by cancer genes is also invaluable, especially for the understanding of functions, for assessing ligandability of potential targets, and for designing new drugs. To complement the wealth of information on the genetics of cancer in COSMIC, the most comprehensive database for cancer somatic mutations available, structural information obtained experimentally has been brought together recently in COSMIC-3D. Even where structural information is available for a gene in the Cancer Gene Census, a list of genes in COSMIC with substantial evidence supporting their impacts in cancer, this information is quite often for a single domain in a larger protein or for a single protomer in a multiprotein assembly. Here, we show that over 60% of the genes included in the Cancer Gene Census are predicted to possess multiple domains. Many are also multicomponent and membrane-associated molecular assemblies, with mutations recorded in COSMIC affecting such assemblies. However, only 469 of the gene products have a structure represented in the PDB, and of these only 87 structures have 90–100% coverage over the sequence and 69 have less than 10% coverage. As a first step to bridging gaps in our knowledge in the many cases where individual protein structures and domains are lacking, we discuss our attempts of protein structure modelling using our pipeline and investigating the effects of mutations using two of our in-house methods (SDM2 and mCSM) and identifying potential driver mutations. This allows us to begin to understand the effects of mutations not only on protein stability but also on protein-protein, protein-ligand and protein-nucleic acid interactions. In addition, we consider ways to combine the structural information with the wealth of mutation data available in COSMIC. We discuss the impacts of COSMIC missense mutations on protein structure in order to identify and assess the molecular consequences of cancer-driving mutations.

Protein structural context of cancer mutations reveals molecular mechanisms and candidate driver genes

Protein structural context of cancer mutations reveals molecular mechanisms and identifies novel candidate driver genes

Leveraging protein dynamics to identify cancer mutational hotspots using 3D structures

Interpretation of cancer mutations using a multiscale map of protein systems

Integrative Computational Framework, Dyscovr, Links Mutated Driver Genes to Expression Dysregulation Across 19 Cancer Types

Cancer Conformational Landscape Shapes Tumorigenesis

Enhancing Cancer Driver Gene Prediction by Protein-Protein Interaction Network

Fundamental immune-oncogenicity trade-offs define driver mutation fitness

Protein Domain-Level Landscape of Cancer-Type-Specific Somatic Mutations

A graph theoretic approach to utilizing protein structure to identify non-random somatic mutations

Protein dynamics analysis identifies candidate cancer driver genes and mutations in TCGA data

Proteome-Scale Investigation of Protein Allosteric Regulation Perturbed by Somatic Mutations in 7,000 Cancer Genomes.

A protein interaction landscape of breast cancer

Chromatin accessibility contributes to simultaneous mutations of cancer genes

Somatic mutation distributions in cancer genomes vary with three-dimensional chromatin structure

A full-proteome, interaction-specific characterization of mutational hotspots across human cancers

Chromatin Accessibility Associates with Protein-Rna Correlation in Human Cancer

Comprehensive characterization of protein–protein interactions perturbed by disease mutations

Machine learning enables pan-cancer identification of mutational hotspots at persistent CTCF binding sites

Mutational landscape and significance across 12 major cancer types

Understanding the impacts of missense mutations on structures and functions of human cancer-related genes: A preliminary computational analysis of the COSMIC Cancer Gene Census